Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Registered Direct Offerings [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Private Placement [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member] June 16, 2021 Registered Direct Offering [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member] Registered Direct Offerings [Member]	Common Stock [Member] Private Placement [Member]	Common Stock [Member] June 16, 2021 Registered Direct Offering [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Registered Direct Offerings [Member]	Additional Paid-in Capital [Member] Private Placement [Member]	Additional Paid-in Capital [Member] June 16, 2021 Registered Direct Offering [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Registered Direct Offerings [Member]	Retained Earnings [Member] Private Placement [Member]	Retained Earnings [Member] June 16, 2021 Registered Direct Offering [Member]	Retained Earnings [Member]	Registered Direct Offerings [Member]	Private Placement [Member]	June 16, 2021 Registered Direct Offering [Member]	Total
Balance (in shares) at Dec. 31, 2020				79,246				19,804,787
Balance at Dec. 31, 2020				$ 792				$ 198,048				$ 110,826,949				$ (108,383,108)				$ 2,642,681
Shares issued to consultant & other (in shares)								2,665
Shares issued to consultant & other								$ 27				(4,075)								(4,048)
Vesting expense												565,082								565,082
Net loss																(3,888,713)				(3,888,713)
Issuance of shares and warrants (in shares)					13,488,098	9,043,766
Issuance of shares and warrants					$ 134,881	$ 90,438			$ 14,877,611	$ 15,974,301							$ 15,012,492	$ 16,064,739
Shares issued pursuant to agreement with former CEO related to accrued interest (in shares)								100,401
Shares issued pursuant to agreement with former CEO related to accrued interest								$ 1,004				142,569								143,573
Exercise of warrants (in shares)								5,247,059
Exercise of warrants								$ 52,471				4,442,799								4,495,270
Shares issued pursuant to convertible debt (in shares)								1,107,544
Shares issued pursuant to convertible debt								$ 11,075				502,936								514,011
Balance (in shares) at Mar. 31, 2021				79,246				48,794,320
Balance at Mar. 31, 2021				$ 792				$ 487,944				147,328,172				(112,271,821)				35,545,087
Balance (in shares) at Dec. 31, 2020				79,246				19,804,787
Balance at Dec. 31, 2020				$ 792				$ 198,048				110,826,949				(108,383,108)				2,642,681
Net loss																				(11,900,662)
Balance (in shares) at Sep. 30, 2021				79,246				65,457,484
Balance at Sep. 30, 2021				$ 792				$ 654,575				167,413,309				(120,283,770)				47,784,906
Balance (in shares) at Mar. 31, 2021				79,246				48,794,320
Balance at Mar. 31, 2021				$ 792				$ 487,944				147,328,172				(112,271,821)				35,545,087
Shares issued pursuant to equity line (in shares)								572,504
Shares issued pursuant to equity line								$ 5,725				582,865								588,590
Shares issued to consultant & other (in shares)								47,424
Shares issued to consultant & other								$ 474				48,238								48,802
Vesting expense												33,243								33,243
Net loss																(2,573,932)				(2,573,932)
Issuance of shares and warrants (in shares)							15,520,911
Issuance of shares and warrants							$ 155,209				$ 19,291,087								$ 19,446,296
Shares issued pursuant to transition agreement with former CEO (in shares)								400,000
Shares issued pursuant to transition agreement with former CEO								$ 4,000				(4,000)								0
Balance (in shares) at Jun. 30, 2021				79,246				65,335,159
Balance at Jun. 30, 2021				$ 792				$ 653,352				167,279,695				(114,845,753)				53,088,086
Shares issued to consultant & other (in shares)								77,191
Shares issued to consultant & other								$ 772				97,997								98,769
Vesting expense								231				17,247								17,478
Net loss																(5,438,017)				(5,438,017)
Vesting expense (in shares)								23,134
Exercise of warrants (in shares)								22,000
Exercise of warrants								$ 220				18,370								18,590
Balance (in shares) at Sep. 30, 2021				79,246				65,457,484
Balance at Sep. 30, 2021				$ 792				$ 654,575				167,413,309				(120,283,770)				47,784,906
Balance (in shares) at Dec. 31, 2021				79,246				65,614,597
Balance at Dec. 31, 2021				$ 792				$ 656,146				167,649,028				(128,040,282)				40,265,684
Shares issued pursuant to equity line (in shares)								120,000
Shares issued pursuant to equity line								$ 1,200				85,685								86,885
Shares issued to consultant & other (in shares)								171,868
Shares issued to consultant & other								$ 1,719				160,403								162,122
Vesting expense												36,518								36,518
Net loss																(3,370,715)				(3,370,715)
Balance (in shares) at Mar. 31, 2022				79,246				65,906,465
Balance at Mar. 31, 2022				$ 792				$ 659,065				167,931,634				(131,410,997)				37,180,494
Balance (in shares) at Dec. 31, 2021				79,246				65,614,597
Balance at Dec. 31, 2021				$ 792				$ 656,146				167,649,028				(128,040,282)				40,265,684
Net loss																				(17,821,524)
Balance (in shares) at Sep. 30, 2022				79,246				78,407,473
Balance at Sep. 30, 2022				$ 792				$ 784,074				174,669,817				(145,861,805)				29,592,878
Balance (in shares) at Mar. 31, 2022				79,246				65,906,465
Balance at Mar. 31, 2022				$ 792				$ 659,065				167,931,634				(131,410,997)				37,180,494
Shares issued pursuant to equity line (in shares)								195,000
Shares issued pursuant to equity line								$ 1,950				147,174								149,124
Shares issued to consultant & other (in shares)								53,662
Shares issued to consultant & other								$ 536				50,134								50,670
Vesting expense												39,383								39,383
Net loss																(10,391,324)				(10,391,324)
Issuance of shares and warrants (in shares)								12,000,000
Issuance of shares and warrants								$ 120,000				6,387,050								6,507,050
Balance (in shares) at Jun. 30, 2022				79,246				78,155,127
Balance at Jun. 30, 2022				$ 792				$ 781,551				174,555,375				(141,802,321)				33,535,397
Shares issued to consultant & other (in shares)								229,212
Shares issued to consultant & other								$ 2,292				91,708								94,000
Vesting expense								231				22,734								22,965
Net loss																(4,059,484)				(4,059,484)
Vesting expense (in shares)								23,134
Balance (in shares) at Sep. 30, 2022				79,246				78,407,473
Balance at Sep. 30, 2022				$ 792				$ 784,074				$ 174,669,817				$ (145,861,805)				$ 29,592,878